Was Once Thought to Be ‘Uncontrollable’ Bleeding The new technology is hailed by its inventors as a life-saving bandage that can succeed where conventional treatment procedures might fail to stop a deadly hemorrhage. More at: https://www.haaretz.com/israel-news/new-israeli-bandage-can-stop-uncontrollable-bleeding-1.5402251
The Angiopoietin 1 Receptor Market 2018 Research Report studies an absolute and exhaustive study on Angiopoietin 1 Receptor industry volume, Market Share, Industry Trends, Angiopoietin 1 Receptor Growth appearances, the wide range of applications, Utilization ratio, Supply including demand analysis, production capacity, Price during the Forecast period from 2018 to 2023. High Use of Angiopoietin 1 Receptor […]
New York City is doubling down on its long-discussed, never-realized dream of building a biotech hub to rival South San Francisco and Boston. The latest iteration of the dream comes backed by a $500 million financing package and a goal to quadruple the amount of R&D space in the city. City officials sketched out the […]
By end of 2019, Regeneron plans to sequence the exomes of all 500,000 people within the UK Biobank resource, all with associated health records, creating an unprecedented resource linking human genetic variations to human biology and disease AbbVie, Alnylam Pharmaceuticals, AstraZeneca, Biogen and Pfizer will join Regeneron to co-fund one of the industry’s most ambitious […]
Pfizer Inc. on Saturday said it would stop trying to discover new drugs for Alzheimer’s disease and Parkinson’s disease, abandoning costly but futile efforts to find effective treatments for the disorders. More at: https://www.wsj.com/articles/pfizer-ends-hunt-for-drugs-to-treat-alzheimers-and-parkinsons-1515267654
UPCOMING: SBIR/STTR WORKSHOP – NIH FOCUSED Wednesday January 17 & Thursday January 18, 2018 (1.5 days) Long Island High Technology Incubator Hosted by the Center for Biotechnology* with support from Empire State Division of Science, Technology and Innovation (NYSTAR) The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) SBIR/STTR programs award over […]
The CRC’s Guide to Coordinating Clinical Research, Third Edition The CRC’s Guide to Coordinating Clinical Research, 3rd edition, is the most comprehensive, easy-to-read training guide for novice and experienced clinical research coordinators. The newly-released third edition includes industry facts, insights on the role and responsibilities, personal experiences to learn from, checklists to help you be […]
Q Therapeutics of the United States and REPROCELL of Japan are teaming up to develop stem cell-based therapies for central nervous system diseases such as ALS and transverse myelitis, or TM. The collaboration will meld Q Therapeutics’ expertise in nerve cell therapy with REPROCELL’s expertise in stem cell treatments. “This collaboration with Q Therapeutics and their scientific co-founder, Dr. […]
Neurologist Dr. Elijah Stommel explains that he sees two newly diagnosed ALS patients each week and that each case is unique. In Andy’s case, the first indications of the disease appeared in his limbs. Andy had the genetic form of the disease and both of his siblings passed away from ALS. Dr. Stommel explains that ALS […]
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Dec. 20, 2017 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that Chaim Lebovits, Chief Executive Officer, will provide a corporate overview at the 10th Annual Biotech Showcase, being held on January 8-10, 2018 at the Hilton San Francisco Union Square in San Francisco, California. more at: http://ir.brainstorm-cell.com/phoenix.zhtml?c=142287&p=irol-newsArticle&ID=2323496